Application of BPTES in preparation of medicine for preventing or treating anthracnose

Abstract

The invention discloses an application of BPTES in preparation of a medicine for preventing or treating anthracnose. The BPTES can inhibit immune cell death and mouse death caused by anthrax toxin and relieve systemic inflammation of mice, so that the BPTES can be used for preparing the medicine for preventing or treating related diseases caused by bacillus anthracis, especially anthrax toxin, and has very important application prospect and development value for anthrozoonosis such as anthrax.

Description

technical field

[0001] The invention relates to the field of medicine, in particular to a medicine for preventing or treating anthrax. Background technique

[0002] Anthrax is an acute infectious disease caused by Bacillus anthracis. Humans are infected by contact with sick animals and their products and by eating meat from sick animals. The main clinical types of anthrax are cutaneous anthrax, inhalational anthrax, intestinal anthrax, and meningitis anthrax, among which cutaneous anthrax is the most common. Clinically, the main manifestations are skin necrosis, ulcers, eschar and extensive edema of surrounding tissues and symptoms of toxemia, hemorrhagic infiltration of subcutaneous and subserosal connective tissue; poor blood coagulation, coal tar-like, and occasionally can cause lung, intestinal and Acute infection of the meninges, which may be accompanied by sepsis. Under natural conditions, herbivores are the most susceptible, and humans are moderately sensitive. It ...

Images